173 related articles for article (PubMed ID: 9595033)
21. Alpha-bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity.
Marchini S; Cirò M; Gallinari F; Geroni C; Cozzi P; D'Incalci M; Broggini M
Br J Cancer; 1999 Jun; 80(7):991-7. PubMed ID: 10362106
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A.
Baraldi PG; Romagnoli R; Beria I; Cozzi P; Geroni C; Mongelli N; Bianchi N; Mischiati C; Gambari R
J Med Chem; 2000 Jul; 43(14):2675-84. PubMed ID: 10893305
[TBL] [Abstract][Full Text] [Related]
23. The discovery of a new potential anticancer drug: a case history.
Cozzi P
Farmaco; 2003 Mar; 58(3):213-20. PubMed ID: 12620417
[TBL] [Abstract][Full Text] [Related]
24. Combination of the new minor groove alkylator tallimustine and melphalan.
Tagliabue G; Filippini C; Ubezio P; D'Incalci M
Eur J Cancer; 1997 Feb; 33(2):284-7. PubMed ID: 9135501
[TBL] [Abstract][Full Text] [Related]
25. Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: synthesis, DNA sequence specificity and biological evaluation.
Gupta R; Liu J; Xie G; Lown JW
Anticancer Drug Des; 1996 Dec; 11(8):581-96. PubMed ID: 9022747
[TBL] [Abstract][Full Text] [Related]
26. DNA minor groove targeted alkylating agents based on bisbenzimidazole carriers: synthesis, cytotoxicity and sequence-specificity of DNA alkylation.
Smaill JB; Fan JY; Denny WA
Anticancer Drug Des; 1998 Dec; 13(8):857-80. PubMed ID: 10335264
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congeners.
Beria I; Baraldi PG; Cozzi P; Caldarelli M; Geroni C; Marchini S; Mongelli N; Romagnoli R
J Med Chem; 2004 May; 47(10):2611-23. PubMed ID: 15115402
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic and antitumor activity of MEN 10710, a novel alkylating derivative of distamycin.
Bigioni M; Salvatore C; Palma C; Manzini S; Animati F; Lombardi P; Pratesi G; Supino R; Zunino F
Anticancer Drugs; 1997 Oct; 8(9):845-52. PubMed ID: 9402311
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, solvolytic stability and cytotoxicity of a modified derivative of CPzI, a pyrazole analog of the alkylation subunit of the antitumor agent CC-1065: effect of the nitrogen substitution on the functional reactivity.
Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Zaid AN; Capolongo L; Cozzi P; Geroni C; Mongelli N
Farmaco; 1997 Dec; 52(12):717-23. PubMed ID: 9648275
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and reactivity of aryl nitrogen mustard-oligodeoxyribonucleotide conjugates.
Reed MW; Lukhtanov EA; Gorn V; Kutyavin I; Gall A; Wald A; Meyer RB
Bioconjug Chem; 1998; 9(1):64-71. PubMed ID: 9460548
[TBL] [Abstract][Full Text] [Related]
31. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxics derived from distamycin A and congeners.
Cozzi P; Mongelli N
Curr Pharm Des; 1998 Jun; 4(3):181-201. PubMed ID: 10197039
[TBL] [Abstract][Full Text] [Related]
33. Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
Beran M; Jeha S; O'Brien S; Estey E; Vitek L; Zurlo MG; Rios MB; Keating M; Kantarjian H
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2377-84. PubMed ID: 9815637
[TBL] [Abstract][Full Text] [Related]
34. Role of DNA minor groove alkylation and DNA cross-linking in the cytotoxicity of polybenzamide mustards.
Turner PR; Denny WA; Ferguson LR
Anticancer Drug Des; 2000 Aug; 15(4):245-53. PubMed ID: 11200500
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574
[TBL] [Abstract][Full Text] [Related]
36. Alkylation specificity for a series of distamycin analogues that tether chlorambucil.
Wyatt MD; Lee M; Hartley JA
Anticancer Drug Des; 1997 Jan; 12(1):49-60. PubMed ID: 9051113
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biophysical evaluation of minor-groove binding C-terminus modified pyrrole and imidazole triamide analogs of distamycin.
Brown T; Taherbhai Z; Sexton J; Sutterfield A; Turlington M; Jones J; Stallings L; Stewart M; Buchmueller K; Mackay H; O'hare C; Kluza J; Nguyen B; Wilson D; Lee M; Hartley JA
Bioorg Med Chem; 2007 Jan; 15(1):474-83. PubMed ID: 17035029
[TBL] [Abstract][Full Text] [Related]
38. Novel benzoyl nitrogen mustard derivatives of pyrazole analogues of distamycin A: synthesis and antileukemic activity.
Baraldi PG; Cozzi P; Geroni C; Mongelli N; Romagnoli R; Spalluto G
Bioorg Med Chem; 1999 Feb; 7(2):251-62. PubMed ID: 10218816
[TBL] [Abstract][Full Text] [Related]
39. Comparison of cell-cycle phase perturbations induced by the DNA-minor-groove alkylator tallimustine and by melphalan in the SW626 cell line.
Erba E; Mascellani E; Pifferi A; D'Incalci M
Int J Cancer; 1995 Jul; 62(2):170-5. PubMed ID: 7622292
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the patterns of DNA alkylation by phenol and amino seco-CBI-TMI compounds: use of a PCR method for the facile preparation of single end-labelled double-stranded DNA.
Gieseg MA; Matejovic J; Denny WA
Anticancer Drug Des; 1999 Feb; 14(1):77-84. PubMed ID: 10363030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
